EUBIOTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

The global eubiotics market is estimated to be valued at USD 7.85 Bn in 2026 and is expected to reach USD 11.92 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033. The global eubiotics market, a rapidly expanding segment of animal nutrition and feed, is experiencing substantial growth. This segment has fundamentally changed how those in animal production manage and improve animal health.

Eubiotics is a term that comes from Greek words "good life," referring to a range of natural animal feed additives that are utilized to support or optimize animal gut microbial balance, as well as animal digestive health. This emerging market segment is comprised of this new and innovative class of animal feed ingredients, which include probiotics, prebiotics, organic acids, essential oils, and phytogenics, used as an alternative to antibiotics.

The importance of the market has risen manifold with the global regulatory restrictions on the use of antibiotics in animal husbandry practices owing to increased concerns about antimicrobial resistance. With increased consumer demands for antibiotic-free meat products and stringent regulatory guidelines on feed additives, scientifically proven eubiotics have come to be recognized as a solution to ensure animal welfare while maintaining efficiency in production. The technology has different modes of action, such as competing against pathogenic microbes, promoting beneficial microbes, utilizing nutrients, and fortifying intestinal functions. Thus, eubiotics play a very important role in sustainable animal husbandry practices.

Market Dynamics

The global eubiotics market has been witnessing a robust growth rate due to a combination of factors, which act as a driving force in the market. The primary driving force behind the market is the rise in global meat consumption, especially in emerging countries, which has led to an increase in the use of eubiotics in the meat production sector. The ban on the use of antibiotic growth promoters in countries like the European Union, the U.S., and the Asia Pacific region has also led to a rise in the market, as farmers and feed manufacturers have been forced to use eubiotics as a substitute. The rise in awareness among consumers has also led to a boost in the market, as consumers prefer food products free from antibiotics. The rise in R&D activities has also led to a boost in the market, as it increases the efficacy of eubiotics.

However, there are a number of restraints that need to be considered, including high production costs compared to conventional feed additives, lack of awareness among small-scale farmers in developing countries, and a lengthy process of seeking approval from different countries, which might act as a restraint for the growth of the market. In addition, there might also be a lack of product quality, which might act as a restraint for the growth of the eubiotics market, as there is a lack of standardization of products, as well as a lack of scientific evidence for certain products.

Nevertheless, there are a number of opportunities arising from the expansion of the aquaculture industry, which will need eubiotics as a sustainable feed ingredient, organic livestock farming, technological advancements, as well as increased government support for sustainable agriculture. Precision nutrition, species-specific eubiotics, as well as pet foods, are opportunities for the eubiotics industry.

Key Features of the Study

• This report provides in-depth analysis of the global eubiotics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global eubiotics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study BASF SE, Koninklijke DSM N.V, Cargill Incorporated, Novozymes A/S, Chr. Hansen Holding A /S, Lesaffre Group, Lallemand Inc, Novus International Inc, Kemin Industries Inc, and DuPont de Nemours Inc
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global eubiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eubiotics market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Probiotics
  • Prebiotics
  • Organic Acids
  • Essential Oils
  • Enzymes
• Livestock Insights (Revenue, USD Bn, 2021 - 2033)
  • Poultry
  • Swine
  • Ruminants
  • Aquaculture
  • Others
• Form Insights (Revenue, USD Bn, 2021 - 2033)
  • Dry
  • Liquid
• Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Gut Health Improvement
  • Immunity Enhancement
  • Feed Efficiency/Yield Improvement
  • Nutrition and Performance
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • BASF SE
  • Koninklijke DSM N.V
  • Cargill Incorporated
  • Novozymes A/S
  • Hansen Holding A/S
  • Lesaffre Group
  • Lallemand Inc
  • Novus International Inc
  • Kemin Industries Inc
  • DuPont de Nemours Inc